Matrine combined with cisplatin synergistically inhibited urothelial bladder cancer cells via down-regulating VEGF/PI3K/Akt signaling pathway.

Liao, Xiao-Zhong; Tao, Lan-Ting; Liu, Jia-Hui; Gu, Yue-Yu; Xie, Jun; Chen, Yuling; Lin, Mei-Gui; Liu, Tao-Li; Wang, Dong-Mei; Guo, Hai-Yan; Mo, Sui-Lin

Liao, Xiao-Zhong; Tao, Lan-Ting; Liu, Jia-Hui; Gu, Yue-Yu; Xie, Jun; Chen, Yuling; Lin, Mei-Gui; Liu, Tao-Li; Wang, Dong-Mei; Guo, Hai-Yan; Mo, Sui-Lin.

Afiliação

Liao XZ; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080 People's Republic of China.
Tao LT; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080 People's Republic of China.
Liu JH; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080 People's Republic of China.
Gu YY; The Second Clinical College, Guangzhou University of Chinese Medicine and Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou, 510120 People's Republic of China.
Xie J; Peking Union Medical College Hospital, Peking Union Medical College, China Academy of Medical Sciences, Beijing, 100730 People's Republic of China.
Chen Y; Sydney Acupuncture & Chinese Medicine Centre, Hurstville, NSW 2220 Australia.
Lin MG; Liwan District Shi wei tang Street Community Health Service Center, Guangzhou, 510360 People's Republic of China.
Liu TL; The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, 518107 People's Republic of China.
Wang DM; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006 People's Republic of China.
Guo HY; Graduate School of China Academy of Chinese Medical Sciences, Beijing, 100700 People's Republic of China.
Mo SL; The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080 People's Republic of China.